About
Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide.
Annual results
Reported figures, USD · revenue down 3.0% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 14.3B | -3.5B | -24.6% | — |
| 2024 | 14.7B | -634M | -4.3% | 2.0B |
| 2023 | 15.4B | 54.0M | 0.4% | 2.4B |
| 2022 | 16.3B | 2.1B | 12.8% | 2.5B |
| 2021 | 17.9B | -1.3B | -7.1% | 2.5B |
Dividends per share
2026 0.48 USD2025 0.48 USD2024 0.48 USD2023 0.48 USD2022 0.48 USD
VTRS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Viatris Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.